These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19149764)

  • 21. Orexigenic/anorexigenic signals in bulimia nervosa.
    Takimoto Y; Inui A; Kumano H; Kuboki T
    Curr Mol Med; 2003 Jun; 3(4):349-60. PubMed ID: 12776990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences.
    Himmerich H; Kan C; Au K; Treasure J
    Pharmacol Ther; 2021 Jan; 217():107667. PubMed ID: 32858054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Food choice in disorders of eating behavior: correlations with the psychopathological aspects of the diseases.
    Segura-García C; De Fazio P; Sinopoli F; De Masi R; Brambilla F
    Compr Psychiatry; 2014 Jul; 55(5):1203-11. PubMed ID: 24703769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crossed prevalence results between subtypes of eating disorder and bipolar disorder: A systematic review of the literature.
    Thiebaut S; Godart N; Radon L; Courtet P; Guillaume S
    Encephale; 2019 Feb; 45(1):60-73. PubMed ID: 29983177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors that predict future onset of each DSM-5 eating disorder: Predictive specificity in high-risk adolescent females.
    Stice E; Gau JM; Rohde P; Shaw H
    J Abnorm Psychol; 2017 Jan; 126(1):38-51. PubMed ID: 27709979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eating disorders during the adolescence: personality characteristics associated with anorexia and bulimia nervosa.
    Barajas Iglesias B; Jáuregui Lobera I; Laporta Herrero I; Santed Germán MÁ
    Nutr Hosp; 2017 Oct; 34(5):1178-1184. PubMed ID: 29130718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.
    McElroy SL; Guerdjikova AI; Mori N; Romo-Nava F
    CNS Drugs; 2019 Jan; 33(1):31-46. PubMed ID: 30523523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy for eating disorders and obesity.
    Powers PS; Bruty H
    Child Adolesc Psychiatr Clin N Am; 2009 Jan; 18(1):175-87. PubMed ID: 19014865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Socio-demographic and psychological risk factors for suicidal behavior among individuals with anorexia and bulimia nervosa: A systematic review.
    Goldstein A; Gvion Y
    J Affect Disord; 2019 Feb; 245():1149-1167. PubMed ID: 30699859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-Discrepancy and Eating Disorder Symptoms Across Eating Disorder Diagnostic Groups.
    Mason TB; Lavender JM; Wonderlich SA; Crosby RD; Engel SG; Strauman TJ; Mitchell JE; Crow SJ; Le Grange D; Klein MH; Smith TL; Peterson CB
    Eur Eat Disord Rev; 2016 Nov; 24(6):541-545. PubMed ID: 27670130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychopharmacological treatment of anorexia nervosa and bulimia. Review and synthesis.
    Johnson C; Stuckey M; Mitchell J
    J Nerv Ment Dis; 1983 Sep; 171(9):524-34. PubMed ID: 6310046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life in eating disorders: a meta-analysis.
    Winkler LA; Christiansen E; Lichtenstein MB; Hansen NB; Bilenberg N; Støving RK
    Psychiatry Res; 2014 Sep; 219(1):1-9. PubMed ID: 24857566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eating disorders, serotonin transporter polymorphisms and potential treatment response.
    Gorwood P
    Am J Pharmacogenomics; 2004; 4(1):9-17. PubMed ID: 14987118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eating Disorder Examination Questionnaire (EDE-Q) and Clinical Impairment Assessment (CIA): clinical norms and functional impairment in male and female adults with eating disorders.
    Dahlgren CL; Stedal K; Rø Ø
    Nord J Psychiatry; 2017 May; 71(4):256-261. PubMed ID: 28084126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Triggers of bulimia and compulsion attacks: validation of the "Start" questionnaire].
    Rigaud D; Jiang T; Pennacchio H; Brémont M; Perrin D
    Encephale; 2014 Sep; 40(4):323-9. PubMed ID: 24091068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weight Suppression in Eating Disorders: a Research and Conceptual Update.
    Lowe MR; Piers AD; Benson L
    Curr Psychiatry Rep; 2018 Aug; 20(10):80. PubMed ID: 30155651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Affective disorders in patients with anorexia nervosa and bulimia nervosa].
    Briukhin AE; Onegina EIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(1):21-6. PubMed ID: 21350407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward a unified theory of serotonin dysregulation in eating and related disorders.
    Brewerton TD
    Psychoneuroendocrinology; 1995; 20(6):561-90. PubMed ID: 8584599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin in human eating disorders.
    Jimerson DC; Lesem MD; Hegg AP; Brewerton TD
    Ann N Y Acad Sci; 1990; 600():532-44. PubMed ID: 2252333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy of the eating disorders: a commentary.
    Advokat C; Kutlesic V
    Neurosci Biobehav Rev; 1995; 19(1):59-66. PubMed ID: 7770198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.